Construction of a flavonoid database for assessing intake in a population-based sample of women on Long Island, New York

Nutrition and Cancer

Volumn 56, Issue 1, 2006, Pages 57-66

  Fink, Brian N ^a   Steck, Susan E ^b   Wolff, Mary S ^c   Kabat, Geoffrey C ^d   Gammon, Marilie D ^a  

^a IL   (United States)

^b University of North Carolina   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; APIGENIN; DAIDZEIN; DELPHINIDIN; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GALLOCATECHIN; GENISTEIN; HESPERETIN; ISOFLAVONE DERIVATIVE; ISORHAMNETIN; KAEMPFEROL; LIGNAN; LIGNAN DERIVATIVE; LUTEOLIN; MALVIDIN CHLORIDE; MATAIRESINOL; MYRICETIN; PELARGONIDIN; QUERCETIN; SECOISOLARICIRESINOL; THEAFLAVIN; THEAFLAVINE 3 GALLATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; AGED; APPLE; APRICOT; ARTICLE; BANANA; BEAN; BEER; BRASSICA; BROCCOLI; CABBAGE; CACAO; CANCER RISK; CARROT; CAULIFLOWER; CHERRY; CONTROLLED STUDY; CORN; DATA BASE; DIETARY INTAKE; FOOD FREQUENCY QUESTIONNAIRE; GRAPEFRUIT; HUMAN; NONHUMAN; ORANGE (FRUIT); PEA; PEACH; PEAR; PEPPER; POTATO; QUESTIONNAIRE; RISK REDUCTION; SPINACH; STRAWBERRY; TEA; TOMATO; TURNIP; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DATABASES, FACTUAL; FEMALE; FLAVANONES; FLAVONOIDS; FLAVONOLS; FOOD ANALYSIS; HUMANS; LIGNANS; MIDDLE AGED; NEW YORK; QUESTIONNAIRES; RISK FACTORS;

CITRUS X PARADISI;

EID: 33846643550     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5601_8     Document Type: Article

References (70)

1. Ren W, Qiao Z, Wang H, Zhu L, and Zhang L: Flavonoids: promising anticancer agents. Med Res Rev 23, 519-534, 2003.
2. Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, and Mabry TJ: Flavonoid effects relevant to cancer. J Nutr 132 (suppl 11), S3482-S3489, 2002.
3. Hertog MG, Hollman PC, Katan MB, and Rromhout D: Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20, 21-29, 1993.
4. Shutt D: The effects of plant oestrogens on animal reproduction. Endeavour 35, 110-113, 1976.
5. Wang TT, Sathyamoorthy N, and Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17, 271-275, 1996.
6. Pouget C, Fagnere C, Basly JP, Besson AE, Champavier Y, et al.: Synthesis and aromatase inhibitory activity of flavanones. Pharm Res 19, 286-291, 2002.
7. Jeong HJ, Shin YG, Kim IH, and Pezzuto JM: Inhibition of aromatase activity by flavonoids. Arch Pharm Res 22, 309-312, 1999.
8. Wang C, Makela T, Hase T, Adlercreutz H, and Kurzer MS: Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 50, 205-212, 1994.
9. Goodin MG, Fertuck KC, Zacharewski TR, and Rosengren RJ: Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol Sci 69, 354-361, 2002.
10. Chang WS, Lee YJ, Lu EJ, and Chiang HC: Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 13, 2165-2170, 1993.
11. Chan WS, Wen PC, and Chiang HC: Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Res 15, 703-707, 1995.
12. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, and Kolonel LN: Intake of flavonoids and lung cancer. JNCI 92, 154-160, 2000.
13. Lahiri-Chatterjee M, Katiyar SK, Mohan RR, and Agarwal R: A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res 59, 622-632, 1999.
14. Tsyrlov IB, Mikhailenko VM, and Gelboin HV: Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochim Biophys Acta 1205, 325-335, 1994.
15. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, et al.: Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18, 957-965, 1997.
16. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, et al.: Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res 57, 246-252, 1997.
17. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, et al.: Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113 (suppl 9B), S71-S88, 2002.
18. Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, et al.: Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas 44 (suppl 1), S9-S20, 2003.
19. Nilsson R: Endocrine modulators in the food chain and environment. Toxicol Pathol 28, 420-431, 2000.
20. Smiciklas-Wright H, Mitchell DC, Mickle SJ, Cook AJ, and Goldman JD: Foods Commonly Eaten in the United States: Quantities Consumed per Eating Occasion and in a Day, 1994-96. University Park, PA: United States Department of Agriculture, Penn State University, 2002.
21. Cassidy A, Bingham S, and Setchell KD: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60, 333-340, 1994.
22. Nagata C, Takatsuka N, Inaba S, Kawakami N, and Shimizu H: Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. JNCI 90, 1830-1835, 1998.
23. Kumar NB, Cantor A, Allen K, Riccardi D, and Cox CE: The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 94, 1166-1174, 2002.
24. Lu LJ, Cree M, Josyula S, Nagamani M, Grady JJ, and Anderson KE: Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women. Cancer Res 60, 1299-1305, 2000.
25. Wang TT, Sathyamoorthy N, and Phang JM: Differential effects of genistein on p52 expression and proliferation in MCF-7 cells are concentration-dependent. Pro AICR 35, A503, 1994.
26. Fotsis T, Pepper M, Adlercrutz H, Hase T, Monttesano R, et al.: Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125, 790-797, 1995.
27. Partridge WM and Mietus LJ: Transport of steroid hormones through the rat blood-brain barrier. J Clin Invest 64, 145-154, 1979.
28. Partridge WM and Mietus LJ: Transport of protein-bound steroid hormones into liver in vivo. Am J Physiol 237, E367-E372, 1979.
29. Partridge WM: Plasma protein-mediated transport of steroid and thyroid hormones. Am J Physiol 252, E157-E164, 1987.
30. Garden GA, Hannan CJ, and Spencer CA: The effect of sex hormone binding globulin (SHBG) on the pituitary testicular axis in hyperthyroid men. Steroids 52, 385-386, 1988.
31. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, et al.: Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11, 815-821, 2002.
32. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, et al.: Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10, 339-344, 2001.
33. Ingram D, Sanders K, Kolybaba M, and Lopez D: Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994, 1997.
34. McCann SE, Freudenheim JL, Marshall JR, and Graham S: Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 133, 1937-1942, 2003.
35. Horn-Ross PL, John EM, Canchola AJ, Stewart SL, and Lee MM: Phytoestrogen intake and endometrial cancer risk. JNCI 95, 1158-1164, 2003.
36. Horn-Ross PL, Hoggatt KJ, and Lee MM: Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 11, 43-49, 2002.
37. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, et al.: Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J Nutr 131, 1826-1832, 2001.
38. Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, et al.: Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14, 805-808, 2005.
39. Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K, et al.: Flavonoid intake and breast cancer risk: a case-control study in Greece. Br J Cancer 89, 1255-1259, 2003.
40. Wang C and Kurzer M: Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28, 236-247, 1997.
41. Evans BA, Griffiths K, and Morton MS: Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147, 295-302, 1995.
42. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, et al.: The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74, 233-254, 2002.
43. Adami HO, Hunter D, and Trichopoulos D: Textbook of Cancer Epidemiology (1st ed). Oxford: Oxford University Press, 2002.
44. We The People: Women and Men in the United States, 2005. http://www.census.gov/prod/2005pubs/censr-20.pdf
45. Potischman N, Swanson CA, Coates RJ, Gammon MD, Brogan DR, et al.: Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer 82, 315-321, 1999.
46. USDA Database for the Flavonoid Content of Selected Foods, 2003. http://www.nal.usda.gov/fnic/foodcomp/Data/Flav/flav.pdf.
47. USDA-Iowa State University Database on the Isoflavone Content of Selected Foods, 2002. http://www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html
48. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, et al.: Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11, 326-331, 2000.
49. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, et al.: Daidzein and genistein contents of vegetables. Br J Nutr 84, 717-725, 2000.
50. Liggins J, Mulligan A, Runswick S, and Bingham SA: Daidzein and genistein content of cereals. Eur J Clin Nutr 56, 961-966, 2002.
51. Reinli K and Block G: Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 26, 123-148, 1996.
52. Price KR and Fenwick GR: Naturally occurring oestrogens in foods-a review. Food Addit Contam 2, 73-106, 1985.
53. Pillow PC, Duphorne CM, Chang S, Contois JH, Strom SS, et al.: Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer 33, 3-19, 1999.
54. Knight DC and Eden JA: Phytoestrogens-a short review. Maturitas 22, 167-175, 1995.
55. Gavaler JS, Rosenblum ER, Deal SR, and Bowie BT: The phytoestrogen congeners of alcoholic beverages: current status. Proc Soc Exp Biol Med 208, 98-102, 1995.
56. Block G, Hartman AM, Dresser CM, Carroll MD, Cannon J, et al.: A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124, 453-469, 1986.
57. Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, et al.: Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29A, 2298-2305, 1993.
58. Gnardellis C, Trichopoulou A, Katsouyanni K, Polychronopoulos E, Rimm EB, et al.: Reproducibility and validity of an extensive semiquantitative food frequency questionnaire among Greek school teachers. Epidemiology 6, 74-77, 1995.
59. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, et al.: Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154, 434-441, 2001.
60. Lu L, Cree M, Josyula S, Nagamani M, Grady JJ, et al.: Increased urinary excretion of 2-hydroxyestrone but not 16a-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res 60, 1299-1305, 2000.
61. Bravo L: Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317-333, 1998.
62. Kuhnau J: The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24, 117-191, 1976.
63. Mazza G: Anthocyanins in grapes and grape products. Crit Rev Food Sci Nutr 35, 341-371, 1995.
64. Imeh U and Khokhar S: Distribution of conjugated and free phenols in fruits: antioxidant activity and cultivar variations. J Agric Food Chem 50, 6301-6306, 2002.
65. Re R, Bramley PM, and Rice-Evans C: Effects of food processing on flavonoids and lycopene status in a Mediterranean tomato variety. Free Radic Res 36, 803-810, 2002.
66. Kim DO, Chun OK, Kim YJ, Moon HY, and Lee CY: Quantification of polyphenolics and their antioxidant capacity in fresh plums. J Agric Food Chem 51, 6509-6515, 2003.
67. Williamson G and Manach C: Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81(suppl 1), S243-S255, 2005.
68. Scalbert A and Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 130(suppl 8), S2073-S2085, 2000.
69. Briefel RR, Flegal KM, Winn DM, Loria CM, Johnson CL, et al.: Assessing the nation's diet: limitations of the food frequency questionnaire. J Am Diet Assoc 92, 959-962, 1992.
70. Nelson M and Bingham SA: Assessment of food composition and nutrient intake. In Design Concepts in Nutritional Epidemiology (2nd ed). Oxford: Oxford University Press, 1998.